Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,689.14
1,471.16
1,258.24
1,003.94
796.51
715.37
578.05
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,689.14
1,471.16
1,258.24
1,003.94
796.51
715.37
578.05
Raw Material Cost
722.03
644.71
587.43
512.83
429.28
392.44
292.37
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
288.34
262.26
248.42
189.63
127.59
96.60
78.55
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
35.59
16.80
3.65
1.66
1.17
0.53
0.55
Selling and Distribution Expenses
283.03
285.96
259.79
164.58
122.87
91.08
91.45
Other Expenses
-18.92
-14.77
-13.05
-8.43
-6.83
-5.77
-4.93
Total Expenditure (Excl Depreciation)
1,139.81
1,061.99
968.83
784.38
612.59
522.91
413.62
Operating Profit (PBDIT) excl Other Income
549.3
409.20000000000005
289.40000000000003
219.60000000000002
183.9
192.5
164.4
Other Income
20.21
37.95
56.52
34.18
9.26
-6.23
45.96
Operating Profit (PBDIT)
677.75
512.15
414.38
313.21
247.95
217.67
235.98
Interest
35.59
16.80
3.65
1.66
1.17
0.53
0.55
Exceptional Items
4.44
2.25
0.00
0.00
0.00
0.62
-1.22
Gross Profit (PBDT)
967.12
826.45
670.81
491.10
367.23
322.94
285.69
Depreciation
128.30
90.21
81.65
70.80
54.77
32.02
27.90
Profit Before Tax
518.30
407.39
329.08
240.75
192.01
185.74
206.31
Tax
69.09
52.60
40.01
32.47
23.73
28.51
20.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
449.21
354.79
289.42
210.96
168.71
157.23
186.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
449.21
354.79
289.42
210.96
168.71
157.23
186.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
-0.35
-2.69
-0.43
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
449.21
354.79
289.07
208.28
168.28
157.23
186.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,657.56
2,331.53
1,967.59
1,676.18
1,506.25
1,385.23
977.28
Earnings per share (EPS)
1.1
0.89
0.72
0.53
0.42
0.39
0.46
Diluted Earnings per share
1.1
0.89
0.72
0.53
0.42
0.39
0.46
Operating Profit Margin (Excl OI)
31.33%
26.1%
21.95%
20.74%
23.09%
26.82%
28.05%
Gross Profit Margin
38.28%
33.82%
32.64%
31.03%
30.98%
30.44%
40.52%
PAT Margin
26.59%
24.12%
23.0%
21.01%
21.18%
21.98%
32.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 14.81% vs 16.93% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 26.61% vs 22.73% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 38.65% vs 32.50% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 111.90% vs 366.67% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Aurisco Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,689.14
0
1,689.14
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,689.14
0
1,689.14
Raw Material Cost
722.03
0
722.03
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
288.34
0
288.34
Power Cost
0
0
0.00
Manufacturing Expenses
35.59
0
35.59
Selling and Distribution Expenses
283.03
0
283.03
Other Expenses
-18.92
0.00
-18.92
Total Expenditure (Excl Depreciation)
1,139.81
0
1,139.81
Operating Profit (PBDIT) excl Other Income
549.33
0.00
549.33
Other Income
20.21
0
20.21
Operating Profit (PBDIT)
677.75
0
677.75
Interest
35.59
0
35.59
Exceptional Items
4.44
0
4.44
Gross Profit (PBDT)
967.12
0
967.12
Depreciation
128.30
0
128.30
Profit Before Tax
518.30
0
518.30
Tax
69.09
0
69.09
Provisions and contingencies
0
0
0.00
Profit After Tax
449.21
0
449.21
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
449.21
0
449.21
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
449.21
0
449.21
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,657.56
0
2,657.56
Earnings per share (EPS)
1.10
0
1.10
Diluted Earnings per share
1.10
0
1.10
Operating Profit Margin (Excl OI)
31.33%
0%
0.00
31.33%
Gross Profit Margin
38.28%
0%
0.00
38.28%
PAT Margin
26.59%
0%
0.00
26.59%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 168.91 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 14.81% vs 16.93% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 44.92 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 26.61% vs 22.73% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 65.75 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 38.65% vs 32.50% in Dec 2024
Annual - Interest
Interest 3.56 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 111.90% vs 366.67% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.33%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






